Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1258

1.

Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.

Tillson M, Niemeyer GP, Welch JA, Brawner W, Swaim SF, Rynders P, Lenz SD, Dean B, Lothrop CD Jr.

Exp Hematol. 2006 Dec;34(12):1759-70.

PMID:
17157174
[PubMed - indexed for MEDLINE]
2.

Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil.

Niemeyer GP, Welch JA, Tillson M, Brawner W, Rynders P, Goodman S, Dufresne M, Dennis J, Lothrop CD Jr.

Transplant Proc. 2005 Dec;37(10):4579-86.

PMID:
16387175
[PubMed - indexed for MEDLINE]
3.

Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.

Storb R, Yu C, Wagner JL, Deeg HJ, Nash RA, Kiem HP, Leisenring W, Shulman H.

Blood. 1997 Apr 15;89(8):3048-54.

PMID:
9108426
[PubMed - indexed for MEDLINE]
Free Article
4.

Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model.

Fukuda T, Kerbauy FR, Gooley T, Santos EB, Storb R, Sandmaier BM.

Transplantation. 2006 Aug 15;82(3):332-9.

PMID:
16906030
[PubMed - indexed for MEDLINE]
5.

Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients.

Trivedi HL, Vanikar AV, Modi PR, Shah VR, Vakil JM, Trivedi VB, Khemchandani SI.

Transplant Proc. 2005 Mar;37(2):737-42.

PMID:
15848518
[PubMed - indexed for MEDLINE]
6.

Induction of allogeneic unresponsiveness in adult dogs. Role of non-DLA histocompatibility variables in conditioning the outcome of bone marrow, kidney, and skin transplantation in radiation chimeras.

Rapaport FT, Bachvaroff RJ, Watanabe K, Hirasawa H, Mollen N, Ferrebee JW, Amos DB, Cannon FD, Blumenstock DA.

J Clin Invest. 1978 Mar;61(3):790-800.

PMID:
76636
[PubMed - indexed for MEDLINE]
Free PMC Article
7.
8.

Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation.

Storb R, Yu C, Barnett T, Wagner JL, Deeg HJ, Nash RA, Kiem HP, McSweeney P, Seidel K, Georges G, Zaucha JM.

Blood. 1999 Aug 1;94(3):1131-6.

PMID:
10419907
[PubMed - indexed for MEDLINE]
Free Article
9.

Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant.

Storb R, Yu C, Zaucha JM, Deeg HJ, Georges G, Kiem HP, Nash RA, McSweeney PA, Wagner JL.

Blood. 1999 Oct 1;94(7):2523-9.

PMID:
10498626
[PubMed - indexed for MEDLINE]
Free Article
11.

DLA-identical bone marrow grafts after low-dose total body irradiation: effects of high-dose corticosteroids and cyclosporine on engraftment.

Yu C, Storb R, Mathey B, Deeg HJ, Schuening FG, Graham TC, Seidel K, Burnett R, Wagner JL, Shulman H, Sandmaier BM.

Blood. 1995 Dec 1;86(11):4376-81.

PMID:
7492799
[PubMed - indexed for MEDLINE]
Free Article
12.

Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates.

Hogan WJ, Little MT, Zellmer E, Friedetzky A, Diaconescu R, Gisburne S, Lee R, Kuhr C, Storb R.

Biol Blood Marrow Transplant. 2003 Aug;9(8):489-95.

PMID:
12931117
[PubMed - indexed for MEDLINE]
13.

Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.

Gammie JS, Li S, Zeevi A, Demetris AJ, Ildstad ST, Pham SM.

Circulation. 1998 Nov 10;98(19 Suppl):II163-8; discussion II168-9.

PMID:
9852899
[PubMed - indexed for MEDLINE]
14.

Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts.

Li H, Colson YL, Ildstad ST.

Transplantation. 1995 Sep 27;60(6):523-9.

PMID:
7570945
[PubMed - indexed for MEDLINE]
15.

Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers.

Foster RD, Ascher NL, McCalmont TH, Neipp M, Anthony JP, Mathes SJ.

Transplantation. 2001 Sep 15;72(5):791-7.

PMID:
11571439
[PubMed - indexed for MEDLINE]
16.

Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts.

Sandmaier BM, Bethge WA, Wilbur DS, Hamlin DK, Santos EB, Brechbiel MW, Fisher DR, Storb R.

Blood. 2002 Jul 1;100(1):318-26.

PMID:
12070043
[PubMed - indexed for MEDLINE]
Free Article
17.

Severe canine hereditary hemolytic anemia treated by nonmyeloablative marrow transplantation.

Zaucha JA, Yu C, Lothrop CD Jr, Nash RA, Sale G, Georges G, Kiem HP, Niemeyer GP, Dufresne M, Cao Q, Storb R.

Biol Blood Marrow Transplant. 2001;7(1):14-24.

PMID:
11215693
[PubMed - indexed for MEDLINE]
18.

Robust tolerance to fully allogeneic islet transplants achieved by chimerism with minimal conditioning.

Luo B, Nanji SA, Schur CD, Pawlick RL, Anderson CC, Shapiro AM.

Transplantation. 2005 Aug 15;80(3):370-7.

PMID:
16082333
[PubMed - indexed for MEDLINE]
19.

Tolerance induction in a large-animal model using total lymphoid irradiation and intrathymic bone marrow.

Horton PJ, Hawthorne WJ, Walters S, Patel T, Stewart GJ, Allen RD, Chapman JR.

Transplantation. 2008 Dec 27;86(12):1830-6. doi: 10.1097/TP.0b013e3181910e67.

PMID:
19104430
[PubMed - indexed for MEDLINE]
20.

A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.

Colson YL, Wren SM, Schuchert MJ, Patrene KD, Johnson PC, Boggs SS, Ildstad ST.

J Immunol. 1995 Nov 1;155(9):4179-88.

PMID:
7594573
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk